05:29 PM EST - Axcan Pharma Inc. : says it will solidify its future as a pharmaceutical company focused on gastrointestinal disorders by being swallowed by American private investment firm TPG Capital in a US$1.3-billion deal. Axcan said its board has approved the cash bid of US$23.35 per share, a 28 percent premium over Axcan's price on the Nasdaq market a day before the offer. Axcan Pharma Inc.
shares T.AXP are trading up 4.66 at $22.62.
